MCID: GST044
MIFTS: 60

Gastritis

Categories: Gastrointestinal diseases, Immune diseases, Infectious diseases

Aliases & Classifications for Gastritis

MalaCards integrated aliases for Gastritis:

Name: Gastritis 12 29 55 44 15 63 73
Acute Gastric Mucosal Erosion 12 73
Erosive Gastropathy 12 73
Erosive Gastritis 12 73
Idiopathic Erosive/hemorrhagic Gastritis 73
Gastritis Erosive 55

Classifications:



External Ids:

Disease Ontology 12 DOID:4029
ICD10 33 K29.7
MeSH 44 D005756
NCIt 50 C26780
SNOMED-CT 68 4556007

Summaries for Gastritis

PubMed Health : 63 About gastritis: The membranes lining the stomach wall protect it from acid and germs. If this protective lining is irritated or damaged, it can become inflamed. Long-lasting inflammations can further damage the stomach lining and lead to stomach (gastric) ulcers.Inflammation of the stomach lining is called gastritis. It is usually caused by certain bacteria or anti-inflammatory medication.There are two kinds of gastritis: acute and chronic. Acute gastritis is typically accompanied by very noticeable stomach and bowel problems that usually go away again on their own after a few days. Chronic gastritis, on the other hand, sometimes goes unnoticed. People may only realize they have it when complications like stomach ulcers arise.

MalaCards based summary : Gastritis, also known as acute gastric mucosal erosion, is related to autoimmune atrophic gastritis and alcoholic gastritis, and has symptoms including dyspepsia and gastric irritation. An important gene associated with Gastritis is PGC (Progastricsin), and among its related pathways/superpathways are Innate Immune System and Defensins. The drugs Rabeprazole and Amoxicillin have been mentioned in the context of this disorder. Affiliated tissues include testes, t cells and colon.

Disease Ontology : 12 A stomach disease that is an inflammation of the lining of the stomach.

Wikipedia : 76 Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a... more...

Related Diseases for Gastritis

Diseases in the Gastritis family:

Autoimmune Gastritis Viral Gastritis
Bacterial Gastritis

Diseases related to Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 314)
# Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 34.0 CHGA GAST
2 alcoholic gastritis 33.9 IL1B PTGS2
3 atrophic gastritis 33.3 ADH7 CHGA CXCL8 GAST GHRL IL1B
4 helicobacter pylori infection 32.4 CXCL1 CXCL8 GAST IL1B S100A8
5 dyspepsia 32.0 CXCL8 GHRL HRH2 PGC PTGS2
6 stomach disease 31.1 CXCL8 GAST GHRL HRH2 IL1B PTGS2
7 gastric cancer 31.0 GAST IL1B IL1RN PTGS2 S100A8 TFF2
8 colitis 30.7 CXCL8 IL1B NOS2 PTGS2
9 esophagitis 30.7 CXCL8 HRH2 IL1B PTGS2
10 duodenal ulcer 30.6 CXCL8 GAST HRH2 IL1B IL1RN S100A8
11 gastric ulcer 30.6 CXCL8 GAST HRH2 IL1B IL1RN PTGS2
12 peptic esophagitis 30.6 CXCL8 HRH2 IL1B
13 peptic ulcer disease 30.5 CXCL8 GAST GHRL HRH2 IL1B IL1RN
14 zollinger-ellison syndrome 30.3 CHGA GAST HRH2
15 gastric adenocarcinoma 30.2 CHGA CXCL8 GAST IL1B IL1RN PTGS2
16 arthritis 30.2 CXCL8 IL1B IL1RN PTGS2
17 crohn's colitis 30.1 CXCL8 IL1B NOS2
18 gastroesophageal reflux 30.0 CXCL8 GAST GHRL HRH2 IL1B PTGS2
19 gastric neuroendocrine neoplasm 29.8 CHGA GAST
20 gastrointestinal system disease 29.8 CXCL8 GAST GHRL IL1B PTGS2 S100A8
21 rheumatoid arthritis 29.8 CXCL1 CXCL8 IL1B IL1RN PTGS2
22 active peptic ulcer disease 29.6 HRH2 PTGS2
23 intestinal disease 29.4 CXCL8 DEFB4A GHRL IL1B PTGS2
24 pneumonia 29.4 CXCL1 CXCL8 IL1B
25 inflammatory bowel disease 29.0 CHGA CXCL1 CXCL8 DEFA5 DEFB1 DEFB4A
26 collagenous gastritis 12.4
27 gastritis, familial giant hypertrophic 12.4
28 bacterial gastritis 12.3
29 herpetic gastritis 12.3
30 granulomatous gastritis 12.3
31 chronic erosive gastritis 12.2
32 lymphocytic gastritis 12.2
33 eosinophilic gastritis 12.2
34 autoimmune gastritis 12.2
35 necrotizing gastritis 12.2
36 pediatric collagenous gastritis 12.1
37 viral gastritis 12.1
38 cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation 12.0
39 fungal gastritis 12.0
40 eosinophilic enteropathy 11.9
41 lubani-al saleh-teebi syndrome 11.2
42 immunodeficiency 12 11.0
43 duodenitis 10.9
44 gastroduodenitis 10.5
45 bile reflux 10.4
46 pernicious anemia 10.4
47 adenocarcinoma 10.4
48 iron metabolism disease 10.3
49 lymphoma 10.3
50 exudative glomerulonephritis 10.3 CXCL8 IL1B

Graphical network of the top 20 diseases related to Gastritis:



Diseases related to Gastritis

Symptoms & Phenotypes for Gastritis

UMLS symptoms related to Gastritis:


dyspepsia, gastric irritation

Drugs & Therapeutics for Gastritis

PubMedHealth treatment related to Gastritis: 63

If you notice that stress, alcohol or nicotine affect your symptoms, you can try to change your diet, stop drinking alcohol, quit smoking and reduce stress in everyday life. If these lifestyle changes are not enough to relieve the symptoms, medication is considered.Gastritis not caused by Helicobacter pylori is usually treated with medication to lower acid levels. Depending on the type and severity of the symptoms, the following drugs can be used:Proton pump inhibitors (PPIs) like omeprazole or pantoprazole reduce the production of stomach acid.H2 blockers such as ranitidine and famotidine also reduce acid production.Antacids like aluminium hydroxide or magnesium hydroxide neutralize the acid already in your stomach.If the gastritis is caused by a Helicobacter infection and is accompanied by noticeable symptoms, it will be treated using a combination of two or three antibiotics and an acid-lowering proton pump inhibitor.If the gastritis is caused by an NSAID painkiller, it is a good idea to consult your doctor about switching to a different painkiller or combining it with an acid-lowering medication. Should an NSAID have to be taken regularly, it is possible to take it along with acid-lowering medication from the start, as a precaution.

Drugs for Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 346)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 117976-89-3 5029
2
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
3
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 81103-11-9 84029
4
Metronidazole Approved Phase 4,Phase 3,Phase 2,Not Applicable 443-48-1 4173
5
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 73590-58-6 4594
6
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
7
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
8
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
9
Mirtazapine Approved Phase 4 61337-67-5, 85650-52-8 4205
10
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
11
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1 51-45-6, 75614-87-8 774
12
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 11953898 44475014
13
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3, 138530-94-6 9578005
14
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
15
Moxifloxacin Approved, Investigational Phase 4,Phase 3 354812-41-2, 151096-09-2 152946
16
Polyestradiol phosphate Approved Phase 4,Phase 3 28014-46-2
17
Tetracycline Approved, Vet_approved Phase 4,Not Applicable 60-54-8 5353990
18
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
19
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
20
Norgestimate Approved, Investigational Phase 4,Phase 3 35189-28-7 6540478
21 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3 979-32-8
22
Wormwood Approved, Experimental Phase 4,Phase 2
23
Ethanol Approved Phase 4,Phase 2,Not Applicable 64-17-5 702
24
Sucralfate Approved Phase 4 54182-58-0 0
25
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
26
Amphotericin B Approved, Investigational Phase 4 1397-89-3 5280965 14956
27
Titanium dioxide Approved Phase 4 13463-67-7
28
Potassium Citrate Approved, Investigational, Vet_approved Phase 4
29
Licorice Approved Phase 4,Phase 2,Phase 3
30
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
31
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
32
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3 93-14-1 3516
33
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 564-25-0 54671203
34
Pantoprazole Approved Phase 4,Phase 3,Not Applicable 102625-70-7 4679
35
Verapamil Approved Phase 4 52-53-9 2520
36
Pectin Approved, Investigational, Vet_approved Phase 4 9000-69-5 441476
37
Ranitidine Approved Phase 4 66357-35-5, 66357-59-3 3001055
38
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 59-30-3 6037
39
Cyanocobalamin Approved, Nutraceutical Phase 4,Not Applicable 68-19-9 44176380
40
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 1 77-92-9 311
41
Ginseng Approved, Investigational, Nutraceutical Phase 4 50647-08-0
42
Serine Approved, Nutraceutical Phase 4 56-45-1 5951
43
Coenzyme Q10 Approved, Investigational, Nutraceutical Phase 4 303-98-0 5281915
44 Rebamipide Investigational Phase 4,Phase 3,Phase 2,Phase 1 90098-04-7
45
Cobalamin Experimental Phase 4,Not Applicable 13408-78-1 6438156
46
Furazolidone Experimental, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 67-45-8 5323714 3435
47 Mosapride Investigational Phase 4,Phase 1 112885-41-3
48
Sulforaphane Investigational Phase 4 142825-10-3, 4478-93-7 5350
49 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
50 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 276)
# Name Status NCT ID Phase Drugs
1 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4 amoxicillin, clarithromycin, metronidazole, rabeprazole
2 Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice Unknown status NCT01273441 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
3 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication Unknown status NCT01464060 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
4 Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia Unknown status NCT02134405 Phase 4 Rebamipide;Placebo (for Esomeprazole);Esomeprazole
5 Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy Unknown status NCT02652884 Phase 4 phosphate and betamethasone acetate, 2 mL.;saline 0.9% NaCl
6 Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia Unknown status NCT03004118 Phase 4 Placebo Oral Tablet;Ursochol oral tablet
7 Mirtazapine Versus Placebo in Functional Dyspepsia Unknown status NCT01240096 Phase 4 Mirtazapine
8 A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Completed NCT01817556 Phase 4 Stillen Tab.;Mucosta Tab.
9 Clinical Effect of Rebamipide on Chronic Gastritis Completed NCT02393430 Phase 4 Rebamipide
10 Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients Completed NCT02356679 Phase 4 Eupasidin-s Tab;Stillen Tab.
11 A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis Completed NCT01284647 Phase 4 Teprenone capsule and placebo of sucralfate;Sucralfate and placebo of teprenone
12 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4 Gastropylor Complex Capsules
13 Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients Completed NCT01119768 Phase 4 Esomeprazole;Esomeprazole
14 Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer Completed NCT01190657 Phase 4 Selbex;Selbex
15 Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment Completed NCT00534443 Phase 4
16 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy Completed NCT02633930 Phase 4 Berberine;clarithromycin;Bismuth;Lansoprazole;amoxicillin
17 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy Completed NCT02296021 Phase 4 Berberine;Bismuth;esomeprazole;amoxicillin;clarithromycin
18 High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication Completed NCT01888237 Phase 4 Double dose of PPI;sequence of drug use
19 Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori Completed NCT01969331 Phase 4
20 A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection Completed NCT01219764 Phase 4 Rabeprazole, metronidazole, Clarithromycin, Amoxicillin
21 Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection Completed NCT02835560 Phase 4 Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy;Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy
22 Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Completed NCT01792700 Phase 4 esomeprazole;tripotassium dicitrate bismuthate;metronidazole;tetracycline;moxifloxacin;amoxicillin
23 Intraluminal Therapy for Helicobacter Pylori Infection Completed NCT03124420 Phase 4 Lansoprazole;Amoxicillin;Clarithromycin
24 Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection Completed NCT02401477 Phase 4 Ilaprazole + Amoxicillin
25 The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia Completed NCT02037776 Phase 4 Rikkunshito;Rikkunshito placebo
26 Efficacy of Banhasasim-tang on Functional Dyspepsia Completed NCT00987805 Phase 4
27 Lansoprazole Versus Mosapride for Functional Dyspepsia Completed NCT00663897 Phase 4 lansoprazole;mosapride
28 The Effect of Anti-inflammatory Analgesics on Pain Following Hallux Valgus Surgery Completed NCT00733421 Phase 4 etoricoxib;tramadol
29 Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Recruiting NCT02047994 Phase 4 Triple therapy
30 Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Recruiting NCT02175186 Phase 4 ALBIS;Placebo
31 Concomitant Versus Hybrid Regimen for H. Pylori Eradication Recruiting NCT03592069 Phase 4 10 day concomitant regimen;14 day hybrid regimen
32 Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy Recruiting NCT03609892 Phase 4 Berberine;Amoxicillin;Esomeprazole;Bismuth;Tetracycline;Furazolidone;Esomeprazole;Bismuth
33 Bismuth Based Quadruple Therapy 10 Days in Children Recruiting NCT03299725 Phase 4 colloidal bismuth sub-citrate
34 The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers Recruiting NCT03342456 Phase 4 Doxycycline Hyclate Enteric-Coated Capsules;Amoxicillin Capsules;Ilaprazole Enteric-Coated Tablets;Furazolidone Tablets;Potassium Citrate Tablets
35 The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori Recruiting NCT03220542 Phase 4 Probiotics;Esomeprazole;Amoxicillin;Clarithromycin
36 Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection Recruiting NCT03521726 Phase 4 Amoxicillin;Rabeprazole, Amoxicillin
37 Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection Recruiting NCT03516669 Phase 4 Clarithromycin;Amoxicillin, Clarithromycin
38 Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation Recruiting NCT02067182 Phase 4 Dabigatran
39 Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety Active, not recruiting NCT02679508 Phase 4 Vonoprazan;Lansoprazole
40 The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study Not yet recruiting NCT02933229 Phase 4 H. pylori eradication
41 Intragastric pH and Bismuth Effect for H. Pylori Eradication Not yet recruiting NCT02894892 Phase 4 (A)Bismuth;(B)Bismuth;(C)Bismuth;(D)Esomeprazole and Bismuth;(E)Esomeprazole and Bismuth;(F)Esomeprazole and Bismuth
42 Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection Not yet recruiting NCT03524833 Phase 4 Metronidazole;Lansoprazole, Amoxicillin, Metronidazole
43 Lansoprazole Preventing Gastroduodenal Stress Ulcerations Terminated NCT00220909 Phase 4 Lansoprazole
44 A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy Terminated NCT02788123 Phase 4 bismuth tripotassium dicitrate;pantoprazole
45 Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia Terminated NCT00590408 Phase 4
46 The Clinical Significance of Acid Rebound in Functional Dyspepsia Terminated NCT01373970 Phase 4 Placebo;Pantoprazole + Placebo
47 Lansoprazole for Subgroups of Functional Dyspepsia Terminated NCT01040455 Phase 4 Lansoprazole;placebo
48 Esomeprazole Treatment for Patients With Lymphocytic Gastritis Unknown status NCT00455754 Phase 3 Esomeprazole
49 A Study to Evaluate the Efficacy and Safety of DA-5204 Unknown status NCT02282670 Phase 3 DA-5204;Stillen tab.
50 A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 Unknown status NCT01813812 Phase 3 DA-6034;Rebamipide 300mg

Search NIH Clinical Center for Gastritis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: gastritis

Genetic Tests for Gastritis

Genetic tests related to Gastritis:

# Genetic test Affiliating Genes
1 Gastritis 29

Anatomical Context for Gastritis

MalaCards organs/tissues related to Gastritis:

41
Testes, T Cells, Colon, Liver, Thyroid, B Cells, Pancreas

Publications for Gastritis

Articles related to Gastritis:

(show top 50) (show all 2500)
# Title Authors Year
1
Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis. ( 30531243 )
2019
2
An ethanol extract of the rhizome of Atractylodes chinensis exerts anti-gastritis activities and inhibits Akt/NF-κB signaling. ( 30218812 )
2019
3
Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand. ( 30507657 )
2019
4
ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer. ( 29434796 )
2018
5
Decrease in<i>PSCA</i>expression caused by<i>Helicobacter pylori</i>infection may promote progression to severe gastritis. ( 29423095 )
2018
6
The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis. ( 29847892 )
2018
7
The First Reported Case of Cytomegalovirus Gastritis in a Patient With End-Stage Renal Disease. ( 29891044 )
2018
8
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition. ( 29307809 )
2018
9
Collagenous gastritis: a rare disease with distinctive endoscopicA findings. ( 29476843 )
2018
10
The key is in the air: transthoracic echocardiogram leading to diagnose emphysematous gastritis. ( 29401257 )
2018
11
Impact of SNP-SNP interactions of DNA repair gene<i>ERCC5</i>and metabolic gene<i>GSTP1</i>on gastric cancer/atrophic gastritis risk in a Chinese population. ( 29434449 )
2018
12
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. ( 29306868 )
2018
13
Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. ( 29768385 )
2018
14
Combined Extracts of <i>Artemisia</i> and Green Tea, Mitigated Alcoholic Gastritis Via Enhanced Heat-shock Protein 27. ( 29566474 )
2018
15
Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic<i>Helicobacter pylori</i>Infection. ( 29378910 )
2018
16
Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect. ( 29353492 )
2018
17
Polymorphism rs7521584 in miRa89429 is associated with the severity of atrophic gastritis in patients with HelicobacterA pylori infection. ( 29956763 )
2018
18
Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method. ( 29665437 )
2018
19
Material basis research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats through integration of urinary metabonomics and SystemsDock. ( 29777900 )
2018
20
Anti-<i>Helicobacter pylori</i> activity and inhibition of gastritis by <i>Allium hookeri</i> extract. ( 29937914 )
2018
21
New Causes for the Old Problem of Bile Reflux Gastritis. ( 29505908 )
2018
22
Extranodal Rosai-Dorfman Disease With Mucosal Involvement of the Stomach in a Background of Autoimmune Atrophic Gastritis. ( 29720012 )
2018
23
Large-cell neuroendocrine carcinoma arising from a gastritis cystica polyposa. ( 29305822 )
2018
24
Utility of a laboratory score in the prediction of altered autonomic nervous system function in autoimmune gastritis. ( 29391305 )
2018
25
Acute Gastritis and Splenic Infarction Caused by Epstein-Barr Virus. ( 29713613 )
2018
26
Pediatric Collagenous Gastritis and Colitis: A Case Series and Review of the Literature. ( 29601434 )
2018
27
Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori. ( 29695148 )
2018
28
High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. ( 29920721 )
2018
29
Host response genes associated with nodular gastritis in H. pylori infection. ( 29415337 )
2018
30
Correlation between serum vitamin B12 level and peripheral neuropathy in atrophic gastritis. ( 29599609 )
2018
31
Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis. ( 29524079 )
2018
32
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer. ( 29896679 )
2018
33
Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer. ( 29865036 )
2018
34
A hyaluronic acid- and chondroitin sulfate-based medical device improves gastritis pain, discomfort, and endoscopic features. ( 29796851 )
2018
35
Emphysematous Gastritis in a Patient with Abdominal Pain after Dialysis. ( 29857151 )
2018
36
Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment. ( 29476289 )
2018
37
Training Effect on the Inter-observer Agreement in Endoscopic Diagnosis and Grading of Atrophic Gastritis according to Level of Endoscopic Experience. ( 29629520 )
2018
38
Hierarchical and Complex System Entropy Clustering Analysis Based Validation for Traditional Chinese Medicine Syndrome Patterns of Chronic Atrophic Gastritis. ( 29565647 )
2018
39
Synchronous double superficial mixed gastrointestinal mucus phenotype gastric cancer with gastritis cystica profunda and submucosal lipoma: A case report. ( 29851789 )
2018
40
Anti-<i>Helicobacter pylori</i> and Anti-Inflammatory Effects and Constituent Analysis of Modified Xiaochaihutang for the Treatment of Chronic Gastritis and Gastric Ulcer. ( 29681980 )
2018
41
Helicobacter pylori Eradication Therapy Ameliorates Latent Digestive Symptoms in Chronic Atrophic Gastritis. ( 29587295 )
2018
42
Symptomatic Non-acidic Reflux in a Patient With Chronic Autoimmune Atrophic Gastritis Successfully Treated With Anti-reflux Surgery. ( 29291616 )
2018
43
Unusual association between erythema nodosum and autoimmune atrophic gastritis. ( 29545439 )
2018
44
A bio-guided approach for the development of a chestnut-based proanthocyanidin-enriched nutraceutical with potential anti-gastritis properties. ( 29928974 )
2018
45
Syphilitic gastritis: a rare presentation of secondary syphilis. ( 29523617 )
2018
46
Colonic Abnormalities in Manitoban Children with <i>Helicobacter pylori</i> Gastritis. ( 29805445 )
2018
47
Helicobacter pylori infection increases sirt2 gene expression in gastric epithelial cells of gastritis patients. ( 29355701 )
2018
48
Treatment of <i>Helicobacter pylori</i> infection in atrophic gastritis. ( 29904244 )
2018
49
Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. ( 29193217 )
2018
50
Collagenous Gastritis Observed by Magnifying Narrow-Band Imaging Endoscopy. ( 29557407 )
2018

Variations for Gastritis

Expression for Gastritis

Search GEO for disease gene expression data for Gastritis.

Pathways for Gastritis

Pathways related to Gastritis according to GeneCards Suite gene sharing:

(show all 23)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.91 CHGA CXCL1 CXCL8 DEFA5 DEFB1 DEFB4A
2
Show member pathways
12.19 CHGA DEFA5 DEFB1 DEFB4A S100A8
3
Show member pathways
12.16 CXCL8 IL1B NOS2 PTGS2
4
Show member pathways
12.04 CXCL8 DEFB4A IL1B NOS2
5
Show member pathways
12.01 CXCL8 IL1B IL1RN NOS2 PTGS2
6
Show member pathways
11.97 CXCL1 CXCL8 DEFB4A IL1B PTGS2 S100A8
7 11.84 CXCL8 IL1B NOS2 PTGS2
8 11.82 CXCL1 IL1B PTGS2
9 11.8 CXCL1 CXCL8 IL1B
10 11.75 CXCL8 IL1B PTGS2
11 11.74 CXCL1 CXCL8 IL1B NOS2
12 11.73 CXCL1 CXCL8 IL1B NOS2 PTGS2
13 11.71 CXCL1 CXCL8 IL1B
14 11.64 CXCL1 CXCL8 IL1B NOS2
15 11.61 CXCL8 IL1B NOS2
16 11.46 CXCL1 CXCL8 IL1B
17 11.42 CXCL8 NOS2 PTGS2
18
Show member pathways
11.42 CXCL8 IL1B NOS2 PTGS2
19
Show member pathways
11.3 PGA3 PGA4 PGA5
20 11.2 CXCL1 IL1B IL1RN NOS2 PTGS2
21 10.89 CXCL8 PTGS2
22 10.71 CXCL1 CXCL8 IL1B IL1RN PTGS2
23 10.21 GAST HRH2

GO Terms for Gastritis

Cellular components related to Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.77 CHGA CXCL1 CXCL8 DEFA5 DEFB1 DEFB4A
2 extracellular region GO:0005576 9.55 ADH7 CHGA CXCL1 CXCL8 DEFA5 DEFB1
3 secretory granule lumen GO:0034774 9.5 DEFA5 GHRL S100A8
4 Golgi lumen GO:0005796 9.43 DEFA5 DEFB1 DEFB4A
5 multivesicular body lumen GO:0097486 9.33 PGA3 PGA4 PGA5

Biological processes related to Gastritis according to GeneCards Suite gene sharing:

(show all 31)
# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.93 CXCL1 CXCL8 IL1B IL1RN NOS2 PTGS2
2 response to lipopolysaccharide GO:0032496 9.91 IL1B NOS2 PTGS2 S100A8
3 chemotaxis GO:0006935 9.91 CXCL1 CXCL8 DEFB1 DEFB4A S100A8
4 defense response GO:0006952 9.89 CXCL1 CXCL8 DEFA5 DEFB1 DEFB4A
5 defense response to bacterium GO:0042742 9.88 CHGA DEFA5 DEFB1 DEFB4A NOS2 S100A8
6 defense response to Gram-positive bacterium GO:0050830 9.86 CHGA DEFA5 DEFB1 DEFB4A
7 memory GO:0007613 9.84 HRH2 IL1B IL1RN PTGS2
8 response to ethanol GO:0045471 9.83 ADH7 IL1B S100A8
9 response to bacterium GO:0009617 9.82 ADH7 DEFB1 NOS2
10 chemokine-mediated signaling pathway GO:0070098 9.81 CXCL1 CXCL8 TFF2
11 response to glucocorticoid GO:0051384 9.8 IL1B IL1RN PTGS2
12 killing of cells of other organism GO:0031640 9.76 CHGA DEFA5 DEFB4A
13 defense response to fungus GO:0050832 9.75 CHGA DEFA5 S100A8
14 innate immune response in mucosa GO:0002227 9.74 DEFA5 DEFB1 NOS2
15 protein catabolic process GO:0030163 9.73 PGA3 PGA4 PGA5 PGC
16 defense response to Gram-negative bacterium GO:0050829 9.72 CHGA DEFA5 DEFB1 DEFB4A NOS2
17 digestion GO:0007586 9.67 PGA3 PGA4 PGA5 PGC
18 neutrophil chemotaxis GO:0030593 9.65 CXCL1 CXCL8 IL1B IL1RN S100A8
19 ovulation GO:0030728 9.64 IL1B PTGS2
20 negative regulation of blood vessel diameter GO:0097756 9.64 CHGA PTGS2
21 cellular response to lipopolysaccharide GO:0071222 9.63 CXCL1 CXCL8 DEFA5 IL1B IL1RN NOS2
22 negative regulation of glutamate secretion GO:0014050 9.62 IL1B IL1RN
23 positive regulation of fever generation GO:0031622 9.61 IL1B PTGS2
24 chronic inflammatory response to antigenic stimulus GO:0002439 9.6 IL1B IL1RN
25 peptidyl-cysteine S-nitrosylation GO:0018119 9.59 NOS2 S100A8
26 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 9.35 CXCL1 CXCL8 DEFA5 DEFB1 DEFB4A
27 antimicrobial humoral response GO:0019730 9.02 CHGA DEFA5 DEFB1 DEFB4A S100A8
28 G protein-coupled receptor signaling pathway GO:0007186 10.17 CXCL1 CXCL8 DEFB1 DEFB4A GAST GHRL
29 regulation of signaling receptor activity GO:0010469 10.02 CXCL1 CXCL8 GAST GHRL IL1B IL1RN
30 immune response GO:0006955 10.02 CXCL1 CXCL8 DEFB1 DEFB4A HRH2 IL1B
31 inflammatory response GO:0006954 10 CXCL1 CXCL8 IL1B IL1RN PTGS2 S100A8

Molecular functions related to Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.46 CXCL1 CXCL8 IL1B IL1RN
2 interleukin-1 receptor binding GO:0005149 9.26 IL1B IL1RN
3 CCR6 chemokine receptor binding GO:0031731 8.96 DEFB1 DEFB4A
4 aspartic-type endopeptidase activity GO:0004190 8.92 PGA3 PGA4 PGA5 PGC

Sources for Gastritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....